Chest Pain After Iron Infusions: Immediate Management
Stop the infusion immediately and keep the IV line open with normal saline—chest pain during IV iron administration is a recognized hypersensitivity reaction that requires prompt intervention to prevent progression to severe anaphylaxis. 1, 2
Immediate Actions
When chest pain develops during IV iron infusion, follow this algorithmic approach:
Stop the infusion immediately and switch IV line to normal saline at keep-vein-open (KVO) rate 1, 2
Assess severity by checking for accompanying symptoms:
- Mild reaction: Isolated chest tightness without other systemic symptoms
- Moderate reaction: Chest tightness plus hypotension (SBP drop ≥30 mmHg or SBP ≤90 mmHg), tachycardia, or shortness of breath
- Severe/anaphylaxis: Chest pain with involvement of ≥2 organ systems, persistent hypotension, respiratory compromise (wheezing, stridor), or loss of consciousness 2
Monitor vital signs continuously (BP, pulse, respiratory rate, O2 saturation, temperature) until stable 1, 2
Treatment Based on Severity
Mild Reaction (Isolated Chest Tightness)
- Monitor for ≥15 minutes with IV normal saline at KVO 2
- Consider IV hydrocortisone 100-500 mg 2
- Consider IV famotidine 20 mg 2
- Document the event thoroughly 1
Moderate Reaction (Chest Pain + Hypotension or Respiratory Symptoms)
- If hypotensive: Recline patient onto back and administer NS bolus 1000-2000 mL 2
- If hypoxemic: Give O2 by mask or nasal cannula 2
- Administer IV hydrocortisone 100-500 mg 2
- Administer IV famotidine 20 mg 2
- Continue monitoring until symptoms resolve 2
Severe Reaction/Anaphylaxis
- Immediately call emergency services or resuscitation team 2
- Administer epinephrine (1 mg/mL) 0.3 mg IM into anterolateral mid-third of thigh; may repeat once 2
- Consider β2 agonist nebulizer (albuterol 0.083%) 2
- Aggressive fluid resuscitation if hypotensive 2
- No further IV iron should be given 1, 2
Understanding the Mechanism
Chest tightness during IV iron infusion represents either:
Fishbane-like reaction (~1% incidence): A transient, non-allergic, self-limited reaction related to labile free iron, not IgE-mediated. Symptoms typically resolve rapidly after stopping the infusion. 1, 3
True hypersensitivity/anaphylaxis (<0.1% incidence): IgE-mediated or complement activation-related pseudoallergy (CARPA) that can progress to life-threatening anaphylaxis. 1, 2, 4
The critical distinction: Fishbane reactions improve within minutes of stopping the infusion and may allow rechallenge at a slower rate. True anaphylaxis does NOT improve after stopping the infusion, worsens progressively, and contraindicates rechallenge. 1
Rechallenge Considerations
If symptoms resolved rapidly (within minutes) and there were no signs of true anaphylaxis:
- May attempt rechallenge at a slower infusion rate under close medical supervision 1
- Ensure resuscitation equipment and emergency medications remain immediately available 1
- Observe continuously for first 10-15 minutes 1
If symptoms persisted, worsened, or involved multiple organ systems:
- Rechallenge is contraindicated 1, 2
- Consider alternative iron formulations only after allergy consultation 2
- Oral iron or alternative management strategies should be pursued 2
Critical Pitfalls to Avoid
- Do not continue the infusion to "see if symptoms resolve"—this risks progression to severe anaphylaxis 1, 2
- Do not assume all chest pain is cardiac—during IV iron infusion, hypersensitivity reaction is the primary concern 1, 2
- Do not give epinephrine IV—IM administration into the thigh is the correct route for anaphylaxis 2
- Do not rechallenge patients who had persistent symptoms or multi-organ involvement—this represents true anaphylaxis with contraindication to future IV iron 1, 2
Prevention for Future Infusions
If rechallenge is deemed appropriate:
- Start infusion at the slowest possible rate 1, 2
- Ensure continuous observation for first 10-15 minutes 1
- Have emergency medications (epinephrine) immediately accessible 1
- Maintain verbal contact with patient to detect early symptoms 1
- Consider premedication with antihistamines and corticosteroids, though evidence for efficacy is limited 2